CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study

MLA

Calvet, Joan, et al. “CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.” Viruses, vol. 12, no. 11, Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13e068ff41abaaeee54985b5bacb5f5a&authtype=sso&custid=ns315887.

APA

Calvet, J., Gratacós, J., Amengual Guedan, M. J., Llop, M., Navarro, M., Moreno, A., Berenguer-Llergo, A., Serrano, A., Orellana, C., Cervantes, M., & Universitat Autònoma de Barcelona. (2020). CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study. Viruses, 12(11).

Chicago

Calvet, Joan, Jordi Gratacós, Maria Jose Amengual Guedan, Maria Llop, Marta Navarro, Amàlia Moreno, Antoni Berenguer-Llergo, et al. 2020. “CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.” Viruses 12 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....13e068ff41abaaeee54985b5bacb5f5a&authtype=sso&custid=ns315887.